CureVac files patent lawsuit against BioNTech over mRNA technology
Pharmaceutical Technology
JULY 6, 2022
CureVac has filed a patent infringement lawsuit against BioNTech in Germany over intellectual property rights of messenger ribonucleic acid (mRNA) technology. Topic sponsors are not involved in the creation of editorial content. The mRNA technology was used for the development of the Covid-19 vaccine.
Let's personalize your content